Filing Details
- Accession Number:
- 0001209191-12-037918
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-12 14:42:45
- Reporting Period:
- 2012-07-10
- Filing Date:
- 2012-07-12
- Accepted Time:
- 2012-07-12 14:42:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337801 | W Randal Scott | 301 Penobscot Drive Redwood City CA 94403 | Ceo, Invitae Corporation* | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-07-10 | 14,800 | $35.96 | 1,200,317 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-10 | 200 | $36.65 | 1,200,117 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-11 | 14,700 | $34.79 | 1,185,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-07-11 | 300 | $35.52 | 1,185,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,298 | Indirect | By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA |
| Common Stock | 3,466 | Indirect | Held in trust for the benefit of Dr.Scott's children, of which Dr. Scott's sister is trustee. |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 11, 2011.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $35.62 to $36.54.
- Includes 4,600 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014 and 1/3 of the shares on February 15, 2015.
- Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on each of February 15, 2013 and 2014, and the 1/3 of the shares that vested on February 15, 2012, net of withholding.
- Represents actual sale price.
- Represents weighted average sale price. Actual sale prices ranged from $34.43 to $35.35.
- Represents weighted average sale price. Actual sale prices ranged from $35.44 to $35.56.
Billionaire Hedge Funds
